Pregnancy of Butilbrometo de Escopolamina in details
Pregnancy is always a special situation where every action or side effect of the drug varies when compared to a situation of a non-pregnant patient. It is not only because the pregnant woman's metabolism differs due to the hormonal and other changes happened to her, but also because every medicine or its metabolite passes to the baby and shows its action there. The only thing is, be cautious, attentive and well supervised when you take any single drug in pregnancy. The interactions can vary in pregnancy, and the dosage may differ as well. Strict supervision of the Physician is mandatory.
Butilbrometo de Escopolamina has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Butilbrometo de Escopolamina is only recommended for use during pregnancy when benefit outweighs risk.
A marginal embryotoxic effect was noted in rabbits given doses yielding plasma concentrations 100 times that normally obtained in humans following transdermal administration.
Butilbrometo de Escopolamina breastfeeding
When a drug is taken when the patient is breast feeding, a part of the drug is secreted in her breast milk and is passed to the baby. The dosage of the medicine to mother and baby are different, and many drugs actions are side effects when you take them without a disease, and what if you the baby takes them without a disease? What if the drug is contraindicated in newborns, infants or children? So, breastfeeding is a very alarming situation when the mother is on medications. Ask your Physician or Pediatrician about the effect of the drug on the baby and how much is excreted in breast milk and if it harms the baby!
There are no data on the excretion of Butilbrometo de Escopolamina into human milk. No adverse effects in nursing infants have been reported in association with Butilbrometo de Escopolamina ingestion via breast milk. Butilbrometo de Escopolamina is considered compatible with breast-feeding by the American Academy of Pediatrics.
"Product Information. Scopace (Butilbrometo de Escopolamina)." Hope Pharmaceuticals, Scottsdale, AZ.
Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
DailyMed. "SCOPOLAMINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
FDA Pharm Classes. "FDA Pharmacological Classification: FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
There are no reviews yet. Be the first to write one!